Incyte
INCY
#991
Rank
A$35.47 B
Marketcap
A$174.03
Share price
-1.64%
Change (1 day)
11.47%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2026 (TTM): A$3.13

According to Incyte's latest financial reports the company's current EPS (TTM) is A$3.15. In 2025 the company made an earnings per share (EPS) of A$9.91 an increase over its 2024 EPS that were of A$0.47.

EPS history for Incyte from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$3.13-68.4%
2025A$9.912029.03%
2024A$0.47-88.39%
2023A$4.0173.38%
2022A$2.31-64.1%
2021A$6.44-408.63%
2020A-$2.09-166.83%
2019A$3.12300%
2018A$0.78-133.33%
2017A-$2.34-378.57%
2016A$0.842700%
2015A$0.03004-106.67%
2014A-$0.45-44.44%
2013A-$0.8150%
2012A-$0.54

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
A$7.88 150.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.07-66.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$46.39 1,370.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$26.10 727.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$3.89 23.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
A-$0.12-103.81%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
A-$0.87-127.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
A-$1.26-140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
A-$0.33-110.48%๐Ÿ‡บ๐Ÿ‡ธ USA